Home › NDC Lookup › RxCUI directory › RxCUI 846192

{21 (dexamethasone 1.5 MG Oral Tablet) } Pack — RxCUI 846192

RxNorm drug concept · Generic pack
RxCUI 846192 Generic pack · GPCK ● Current RxNorm concept 4 FDA products 6 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI846192
Official name{21 (dexamethasone 1.5 MG Oral Tablet) } Pack
Concept typeGeneric pack (GPCK)
RxNorm statusCurrent RxNorm concept
Also known asdexAMETHasone 1.5 MG Tablet 6 Day 21 Count Pack
FDA products mapped4
Package NDCs mapped6
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Dexamethasone Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It calms inflammation and treats many conditions, including severe allergic reactions, arthritis flares, certain skin diseases, brain swelling, and adrenal problems. It can also be...
  • A healthcare professional gives it into a vein, muscle, joint, or lesion, depending on why you need it. Your dose is tailored to you and is usually brought down to the lowest effec...
  • If you have been treated for more than a few days, it is usually stopped gradually. Stopping too fast can cause low adrenal function that may last for months. Never change the plan...
  • Call right away for signs of infection, a severe allergic reaction, vision changes, or eye pain. Steroids can hide infection, so even mild symptoms matter. Seek urgent help for sud...
📖 Read our full Dexamethasone Injection guide →

🕸️ Concept Web — How {21 (dexamethasone 1.5 MG Oral Tablet) } Pack Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept {21 (dexamethasone 1.5 MG Oral Tablet) } Pack RxCUI 846192

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Dexamethasone 3264
  2. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Dexamethasone Oral Tablet 371729
    • Dexamethasone Oral Product 1154535
    • Dexamethasone Pill 1154537
    • Pack 746839
    • Oral Product 1151131
    • Pill 1151133
  3. Clinical & branded drugs 2

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

  4. Packs 3

    Fixed collections of drugs packaged and sold together, like dose packs.

Showing up to 8 concepts per family — 12 of 12 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Dexamethasone 1.5 MG Oral Tablet SCD · 197580
  • Dexamethasone 1.5 MG SCDC · 315777
  • Dexamethasone Oral Tablet SCDF · 371729
  • Dexamethasone Oral Product SCDG · 1154535
  • Dexamethasone Pill SCDG · 1154537

Brand-Name Concepts

📦 FDA Products & Package NDCs

4 products · 6 package NDCs
6 package NDCs map to RxCUI 846192 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
68047-0702-01 100 TABLET in 1 BOTTLE (68047-702-01) Dexamethasone 1.5 mg Larken Laboratories, Inc. 2017-09-01
68047-0702-21 21 TABLET in 1 DOSE PACK (68047-702-21) Dexamethasone 1.5 mg Larken Laboratories, Inc. 2018-08-08
68047-0702-35 35 TABLET in 1 DOSE PACK (68047-702-35) Dexamethasone 1.5 mg Larken Laboratories, Inc. 2018-08-08
68047-0702-51 51 TABLET in 1 DOSE PACK (68047-702-51) Dexamethasone 1.5 mg Larken Laboratories, Inc. 2018-08-08
71205-0012-21 1 BLISTER PACK in 1 CARTON (71205-012-21) / 21 TABLET in 1... TaperDex 6-day Proficient Rx LP 2018-04-02
82804-0059-21 21 TABLET in 1 DOSE PACK (82804-059-21) Dexamethasone 1.5 mg Proficient Rx LP 2024-01-18
Observed labelers: Larken Laboratories, Inc. (4) · Proficient Rx LP (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ea · median
$0.1967
Range $0.1967–$0.1967 · middle 50% $0.1967–$0.1967 · 1 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.